Evaluation of Real-Life Chemoimmunotherapy Combination in Patients with Metastatic Small Cell Lung Carcinoma (SCLC): A Multicentric Case–Control Study

SIMPLE SUMMARY: Chemoimmunotherapy (CT-IO) is the standard first-line treatment of advanced small cell lung cancer (SCLC). However, very limited efficacy data from real-life use of this combination are available. Moreover, patients included in pivotal phase III trials were highly selected. We conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezzedine, Rémy, Canellas, Anthony, Naltet, Charles, Wislez, Marie, Azarian, Reza, Seferian, Andrei, Giroux Leprieur, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526821/
https://www.ncbi.nlm.nih.gov/pubmed/37760561
http://dx.doi.org/10.3390/cancers15184593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526821/
https://www.ncbi.nlm.nih.gov/pubmed/37760561
http://dx.doi.org/10.3390/cancers15184593

Ejemplares similares